Han Chiu
Chief Technology Officer @ Click Therapeutics
About Han Chiu
Han Chiu is the Chief Technology Officer at Syneos Health with expertise in developing prescription digital therapeutics and conducting decentralized clinical trials.
Known information
Han Chiu serves as the Chief Technology Officer at Syneos Health, where he leverages his extensive expertise in developing prescription digital therapeutics. He has participated in pivotal studies such as ReMMi-D for migraine treatment and the CONVOKE Study for schizophrenia treatment. Chiu has been instrumental in the development of CT-155, a digital therapeutic for schizophrenia, and Rejoyn™, a digital therapeutic for Major Depressive Disorder. He also played a key role in the launch of Clickotine®, a digital therapeutic aimed at smoking cessation. With a background in cognitive and neurobehavioral mechanisms, Chiu has experience in conducting fully remote and decentralized clinical trials and has collaborated with pharmaceutical companies like Boehringer Ingelheim.
About Click Therapeutics
Click Therapeutics develops and commercializes software as prescription medical treatments, focusing on cognitive and neurobehavioral mechanisms to address unmet medical needs. Headquartered in New York, the company collaborates with major healthcare firms and has received significant funding and recognition for its innovative digital therapeutics.